Fig. 3.
![Fig. 3. Proliferation of PBMC in response to allogeneic naive AML blasts or leukemia-derived DC (patient TA). Allo-MLR was performed with 105 allogeneic PBMC as responder cells and different numbers of thawed AML blasts or leukemia-derived DC at stimulator:responder ratios ranging from 0.5:1 to 0.06:1. Leukemic DC were derived from 20-day cultures. Proliferation was measured 5 days after stimulation by [3H]-thymidine incorporation.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/94/6/10.1182_blood.v94.6.2048/5/blod41821003x.jpeg?Expires=1735515263&Signature=ie9q8RKScbGuAY661a~UV~nL0Nh9KpjE49wTlvQZs6YPI7ZLz2rvfWQllutu1mufk4Io2M~WFl2U91OhVxzZS7z-z~4sgfT92CZmUAcVnPLFhbXTcJs~9-vxSSc60AlX~ixcGCVXso8QncuIkr4d0c~ODvlIn7~xIesPZsw7ntJ-YYzPfS-ueA6w~Ecm4~kPW1z03Cx-StruphAmXzcqvK14eujIzmb0tZgdwirgA54DGXnMUvyr5~G-ijh50-5InJFlJ-wOtscPtXrF1rN5Ph4~t3ZYyAQFOTJe6JNdSMhFztZEtzda25CdwvFOzUrQBLnrwmnJyyeRO6EP1ctD1Q__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Proliferation of PBMC in response to allogeneic naive AML blasts or leukemia-derived DC (patient TA). Allo-MLR was performed with 105 allogeneic PBMC as responder cells and different numbers of thawed AML blasts or leukemia-derived DC at stimulator:responder ratios ranging from 0.5:1 to 0.06:1. Leukemic DC were derived from 20-day cultures. Proliferation was measured 5 days after stimulation by [3H]-thymidine incorporation.
